ArticleTheranostics2020

Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.

Yongqi Zhen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.